Plasma Anti-inflammatory Cytokines and Monocyte Human Leucocyte Antigen-DR Expression in Patients with Acute Pancreatitis

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 2, 2004, Pages 178-187

  Mentula, P ^a   Kylanpaa M L ^b   Kemppainen, E ^b   Jansson, S E ^b   Sarna, S ^b   Puolakkainen, P ^b   Haapiainen, R ^b   Repo, H ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

Acute necrotizing; Cytokines; HLA DR antigens; Immunologic; Interleukins; Monitoring; Multiple organ failure; Pancreatitis

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6;

ACUTE PANCREATITIS; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SAMPLE SIZE; SUPERINFECTION;

ACUTE DISEASE; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTERLEUKINS; MALE; MULTIPLE ORGAN FAILURE; PANCREATITIS; PROGNOSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 10744228831     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310008278     Document Type: Article

References (49)

1. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999;340:1412-7.
2. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586-90.
3. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999;86:1020-4.
4. Heath D, Alexander D, Wilson C, Larvin M, Imrie C, McMahon M. Which complications of acute pancreatitis are most lethal? A prospective multicenter clinical study of 719 episodes. Gut 1995;36:A478.
5. De Beaux A, Palmer K, Carter D. Factors influencing morbidity and mortality in acute pancreatitis: an analysis of 279 cases. Gut 1995;37:121-6.
6. Tenner S, Sica G, Hughes M, Nordhoek E, Feng S, Zimmer M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899-903.
7. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
8. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
9. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-7.
10. Garcia-Sabrido J, Valdecantos E, Bastida E, Tellado JM. The anergic state as a predictor of pancreatic sepsis. Zentralbl Chir 1989;114:114-20.
11. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000;47:546-52.
12. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. BrJ Surg 1996;83349-53.
13. Simovic MO, Bonham MJ, Abu-Zidan FM, Windsor JA. Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis. Crit Care Med 1999;27:2662-5.
14. Chen CC, Wang SS, Lu RH, Chang FY, Lee SD. Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis. Gut 1999;45:895-9.
15. Opal SM, Wherry JC, Grint P. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis 1998;27:1497-507.
16. Koppelman B, Neefjes JJ, deVries JE, de Waal Malefyt R. Interleukin-10 down-regulates MCH class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997;7:861-71.
17. Tonegawa S. Antibody and T-cell receptors. JAMA 1988;259:1845-7.
18. Wolk K, Docke W-D, von Baehr V, Volk HD, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000;96:218-23.
19. Döcke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, et al. Monocyte deactivation in septic patients: restoration by IFN-γtreatment. Nature Med 1997;3:678-81.
20. Lin R, Astiz M, Saxon J, Rackow E. Altered leukocyte immunophenotypes in septic shock. Chest 1993;104:847-53.
21. Sachse C, Prigge M, Cramer G, Pallua N, Henkel E. Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clin Chem Lab Med 1999;37:193-8.
22. Livingston DH, Appel SH, Wellhausen SR, Sonnenfeld G, Polk HC. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988;123:1309-12.
23. Wakefield CH, Carey PD, Foulds S, Monson JRT, Guillou PJ. Changes in major histocompatibility complex class II expression on monocytes and T-cells of patients developing infection after surgery. Br J Surg 1993;80:205-9.
24. Richter A, Nebe T, Wendl K, Schuster K, Klaebisch G, Quintel M, et al. HLA-DR expression in acute pancreatitis. Eur J Surg 1999;165:947-51.
25. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC. HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 1991;161:639-45.
26. Hershman MJ, Chaedle WG, Wellhausen SR, Davidson PF, Polk HC. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patients. Br J Surg 1990;77:204-7.
27. Brivet FG, Emilie D, Galanaud P. Pro-and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Crit Care Med 1999;27:749-55.
28. Kylänpää-Bäck M-L, Takala A, Kemppainen E, Puolakkainen P, Kautiainen H, Jonsson SE, et al. Cellular markers of systemic inflammation and immunosuppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol 2001;36:1100-7.
29. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MS, Neoptalemos JP, McKay C, et al. Double blind, randomised, placebo controlled study of platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001;48:62-9.
30. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001;22:274-8.
31. Mentula P, Kylänpää-Bäck M-L, Kemppainen E, Takala A, Jansson SE, Kautiainen H, et al. Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci 2003;105:409-17.
32. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
33. Ranson J, Rifkind K, Roses D, Fink S, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
34. Marshall J, Cook D, Christnou N, Bernard G, Sprung C, Sibbald W. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
35. Overton WR. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry 1988;9:619-26.
36. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-72.
37. Van Laethem JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Deviere J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998;43:408-13.
38. Gloor B, Blinman TA, Rigberg DA, Todd KE, Lane JS, Hines OJ, et al. Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 2000;21:414-20.
39. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-5.
40. Lin RY, Astiz ME, Saxon JC, Saha DC, Rackow EC. Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994;22:1595-602.
41. Satoh A, Miura T, Satoh K, Masamunc A, Yamagiwa T, Sakai Y, et al. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 2002;25:245-50.
42. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation: rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996;22:474-81.
43. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schuttler J. Coincidence of pro-and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002;30:1015-23.
44. Zimmerman JJ. Congenital heart disease, cardiopulmonary bypass, systemic inflammatory response syndrome, compensatory anti-inflammatory response syndrome, and outcome: evolving understanding of critical care inflammation immunology. Crit Care Med 2002;30:1178-9.
45. Cavaillon JM, Adib-Conquy M, Cloez-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res 2001;7:85-93.
46. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002;30:S58-63.
47. Sainio V, Kemppainen E, Puolakkainen P, Taavitsainen M, Kivisari L, Valtonen V, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995;346:663-7.
48. Windsor AC, Kanwar S, Li AG, Barnes E, Guthrie JA, Spark JI, et al. Compared with parenteral nutrition, enterai feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998;42:431-5.
49. Neoptolemos J, Carr-Locke D, London N, Bailey I, James D, Fossard D. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 1988;2:979-83.